434 related articles for article (PubMed ID: 16906789)
1. Memantine: a review of its use in Alzheimer's disease.
Robinson DM; Keating GM
Drugs; 2006; 66(11):1515-34. PubMed ID: 16906789
[TBL] [Abstract][Full Text] [Related]
2. [Mémantine (Ebixa): a new therapeutic strategy for the treatment of moderate to severe forms of Alzheimer's disease].
Gallarda T; Lôo H
Encephale; 2004; 30(1):69-79. PubMed ID: 15029079
[TBL] [Abstract][Full Text] [Related]
3. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.
Lipton SA
J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S61-74. PubMed ID: 15665416
[TBL] [Abstract][Full Text] [Related]
4. Memantine: a pharmacoeconomic review of its use in moderate-to-severe Alzheimer's disease.
Plosker GL; Lyseng-Williamson KA
Pharmacoeconomics; 2005; 23(2):193-206. PubMed ID: 15748093
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of memantine for the treatment of Alzheimer's disease.
Ferris SH
Expert Opin Pharmacother; 2003 Dec; 4(12):2305-13. PubMed ID: 14640929
[TBL] [Abstract][Full Text] [Related]
6. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
Sonkusare SK; Kaul CL; Ramarao P
Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530
[TBL] [Abstract][Full Text] [Related]
7. Memantine: a review of studies into its safety and efficacy in treating Alzheimer's disease and other dementias.
Thomas SJ; Grossberg GT
Clin Interv Aging; 2009; 4():367-77. PubMed ID: 19851512
[TBL] [Abstract][Full Text] [Related]
8. Management of moderate to severe Alzheimer's disease: focus on memantine.
Dominguez E; Chin TY; Chen CP; Wu TY
Taiwan J Obstet Gynecol; 2011 Dec; 50(4):415-23. PubMed ID: 22212311
[TBL] [Abstract][Full Text] [Related]
9. Memantine for dementia.
Areosa Sastre A; McShane R; Sherriff F
Cochrane Database Syst Rev; 2004 Oct; (4):CD003154. PubMed ID: 15495043
[TBL] [Abstract][Full Text] [Related]
10. The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism.
Lipton SA
Curr Alzheimer Res; 2005 Apr; 2(2):155-65. PubMed ID: 15974913
[TBL] [Abstract][Full Text] [Related]
11. Memantine: a review of its use in moderate to severe Alzheimer's disease.
McKeage K
CNS Drugs; 2009 Oct; 23(10):881-97. PubMed ID: 19739697
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of memantine in the treatment of Alzheimer's disease].
Molinuevo Guix JL; Lladó Plarrumaní A
Neurologia; 2005 Dec; 20(10):686-91. PubMed ID: 16317590
[TBL] [Abstract][Full Text] [Related]
13. Use of memantine for the treatment of dementia.
Lo D; Grossberg GT
Expert Rev Neurother; 2011 Oct; 11(10):1359-70. PubMed ID: 21955192
[TBL] [Abstract][Full Text] [Related]
14. Memantine hydrochloride: pharmacological and clinical profile.
Möbius HJ; Stöffler A; Graham SM
Drugs Today (Barc); 2004 Aug; 40(8):685-95. PubMed ID: 15510240
[TBL] [Abstract][Full Text] [Related]
15. Spotlight on memantine in moderate to severe Alzheimer's disease.
McKeage K
Drugs Aging; 2010 Feb; 27(2):177-9. PubMed ID: 20104942
[TBL] [Abstract][Full Text] [Related]
16. Memantine.
Jarvis B; Figgitt DP
Drugs Aging; 2003; 20(6):465-76; discussion 477-8. PubMed ID: 12710865
[TBL] [Abstract][Full Text] [Related]
17. N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer's disease, vascular dementia and Parkinson's disease.
Olivares D; Deshpande VK; Shi Y; Lahiri DK; Greig NH; Rogers JT; Huang X
Curr Alzheimer Res; 2012 Jul; 9(6):746-58. PubMed ID: 21875407
[TBL] [Abstract][Full Text] [Related]
18. Once-daily memantine: a guide to its use in moderate to severe Alzheimer's disease in the EU.
Lyseng-Williamson KA; McKeage K
Drugs Aging; 2013 Jan; 30(1):51-8. PubMed ID: 23229767
[TBL] [Abstract][Full Text] [Related]
19. Memantine treatment in patients with mild to moderate Alzheimer's disease: results of a randomised, double-blind, placebo-controlled 6-month study.
Bakchine S; Loft H
J Alzheimers Dis; 2008 Feb; 13(1):97-107. PubMed ID: 18334761
[TBL] [Abstract][Full Text] [Related]
20. Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies.
Wilcock GK; Ballard CG; Cooper JA; Loft H
J Clin Psychiatry; 2008 Mar; 69(3):341-8. PubMed ID: 18294023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
